JESSICA CINCOTTA: Open Payments
NPI 1679297204 · VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 14 payments from 8 companies in 2025. Trend: 2023 $32 · 2024 $288 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $185 |
| Gilead Sciences, Inc. | 3 | $184 |
| GENZYME CORPORATION | 1 | $50 |
| ABBVIE INC. | 1 | $31 |
| Organon LLC | 2 | $30 |
| Lilly USA, LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Philips North America LLC | 1 | $15 |
Products named: BREZTRI, AIRSUPRA, DUPIXENT, UBRELVY, NEXPLANON, MOUNJARO, Ozempic, Diagnostic ECG Service.
Industry payments across CA — which companies pay providers there.
